Abstract
A critical review of the literature on the effects of antihypertensive drugs on the fetus in pregnant women is presented. The survey covers the alpha-adrenergic receptor agonists, beta-blockers including topical eye medications, alpha-beta blockers, calcium antagonists, diuretics, and angiotensin-converting enzyme (ACE) inhibitors. The lack of data on angiotensin II receptor blockers is noted although effects are considered to be similar to those reported with ACE inhibitors and therefore to be avoided. Analysis of the literature underscores that some antihypertensive drugs can be used safely at certain stages of pregnancy, while others are suspect and to be avoided at all costs. The lack of placebo-controlled studies on the treatment of severe hypertension in pregnancy due to ethical considerations is discussed against the background of the pressing need to treat these women despite the possible deleterious effects of antihypertensive drugs
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Working Group Report on High Blood Pressure in Pregnancy Am J Obstet Gynecol 1990; 163: 1691–1712 NIH publication N000–3029. Revised July 2000
De Swiet M . Maternal blood pressure and birthweight (editorial) Lancet 2000; 355: 81
Von Dadelszen P et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis Lancet 2000; 355: 87–92
Sibai BM et al. Risk factors for preeclampsia abruption placental, and adverse neonatal outcomes among women with chronic hypertension N Engl J Med 1998; 338: 701–705
Rey E, Couturier A . The prognosis of pregnancy in women with chronic hypertension Am J Obstet Gynecol 1994; 171: 410–416
Montan S et al. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension Am J Obstet Gynecol 1993; 168: 152–156
Sibai BM . Treatment of hypertension in pregnant women N Engl J Med 1996; 335: 257–265
Lindheimer MD . Hypertension in pregnancy Hypertension 1993; 22: 127–137
Kirsten R, Nelson K, Kirsten D, Heintz B . Clinical pharmakokinetics of vasodilators – Part II Clin Pharmacokinet 1998; 35: 9–36
Sibai MB et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy Am J Obstet Gynecol 1990; 162: 960–967
Pickles CJ, Symonds EM, Pipkin FB . The fetal outcome in a randomized double blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension Br J Obstet Gynecol 1989; 96: 38–43
Pickles CJ, Broughton Pipkin F, Symonds EM . A randomized placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension Br J Obstet Gynecol 1992; 99: 964–968
Butters L, Kennedy S, Rubin PC . Atenolol in essential hypertension during pregnancy BMJ 1990; 301: 587–589
Lip GYH et al. Effect of atenolol on birth weight Am J Cardiol 1997; 79: 1436–1438
Magee LA, Omstein MP, von Dsadelszen P . Fortnightly review: management of hypertension in pregnancy BMJ 1999; 318: 1332–1336
Lydakis C et al. Atenolol and fetal growth in pregnancies complicated by hypertension Am J Hypertens 1999; 12: 541–547
Easterling TR et al. Prevention of preeclampsia a randomized trial of atenolol in hyperdynamicpatients before onset of hypertension. Obstet Gynecol 1999; 93: 725–733
Churchill D, Bayliss H, Beevers G . Fetal growth restriction Lancet 2000; 355: 1366–1367
Magee L . Authors reply Lancet 2000; 355: 1367
Magee LA et al. The generalizability of trial data; a comparison of beta blocker trial participants with a prospective cohort of women taking beta blockers in pregnancy Eur J Obstet Gynecol Reprod Biol 2001; 94: 205–210
Wagebvoort AM et al. Topical timolol therapy in pregnancy: is it safe for the fetus? Teratology 1998; 58: 258–262
Van Tetten GR . Cardiovascular effects of timolol in the anesthetized pregnant ewe and fetus Proc West Pharmacol Soc 1980; 23: 191–195
Kooner KS, Zimmerman TJ . Antiglaucoma therapy during pregnancy – Part I Ann Ophthalmol 1988; 20: 166–169
Bourget P et al. Weak placental passages of prazosin (Alpress) during the third trimester of pregnancy J Gynecol Obstet Biol Reported Paris 1993; 22: 871–874
Hurst JA et al. Transverse limb deficiency, facial clefting and hypoxic renal damage: an association with treatment of maternal hypertension? Clin Dysmorphol 1995; 4: 359–363
Kaler SG et al. Hypertrichosis and congenital anomalies associated with maternal use of minoxidil Pediatrics 1987; 79: 434–436
Carlson RG, Feenstra ES . Toxicologic studies with the hypotensive agent minoxidil Toxicol Appl Pharmacol 1977; 39: 1–11
Magee LA et al. The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study Am J Obstet Gynecol 1996; 174: 823–828
Gruppo di studio Ipertensione in Gravidanze. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy Br J Obstet Gynaecol 1998; 105: 718–722
Sibai BM, Grossman RA, Grossman HG . Effects of diuretics on plasma volume in pregnancies with long term hypertension Am J Obstet Gynecol 1984; 150: 831–835
Arias F, Zamora J . Antihypertensive treatment and pregnancy outcome inpatients with mild chronic hypertension Obstet Gynecol 1979; 53: 489–494
Collins R, Yusuf S, Peto R . Overview of randomised trials of diuretics in pregnancy BMJ 1985; 290: 17–23
Davidson D, Stalcup SA, Mellins RB . Captopril administration to the pregnant guinea pig inhibits fetal angiotensin converting enzyme activity Pediatr Res 1981; 15: 658
Broughton-Pipkin F, Wallace CP . The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus Br J Pharmacol 1986; 87: 533–542
Broughton-Pipkin F, Symonds EM, Turner SR . The effect of captopril (SQ14,255) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit J Physiol 1982; 323: 415–422
Ferris TF, Weir EK . Effect of captopril on uterine blood flow and prostaglandin synthesis in the pregnant rabbit J Clin Invest 1983; 71: 809–815
Fiocchi R et al. Captopril during pregnancy Lancet 1984; 2: 1153
Coen G et al. Successful treatment of long lastingsevere hypertension with captopril during a twinpregnancy Nephron 1985; 40: 498–500
Brent RL . Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical tetralogy counselors Tetralogy 1991; 43: 543–546
Guignard JP . Burgener F, Calame A Persistent anuria in a neonate: a side effect of captopril? J Pediatr Nephrol 1981; 2: 133
Scott AA, Purohit DM . Neonatal renal failure: a complication of maternal antihypertensive therapy Am J Obstet Gynecol 1989; 160: 1223–1224
Rothberg AD, Lorenz R . Can captopril cause fetal and neonatal renal failure? Pediatr Pharmacol 1984; 4: 189–192
Cuniff C et al. Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use Am J Obstet Gynecol 1990; 162: 187–189
Schubiger G, Flury G, Nussberger J . Enalapril for pregnancy induced hypertension: Acute renal failure in neonate Ann Intern Med 1988; 108: 215–216
Barr M Jr, Cohen MM Jr . ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection Teratology 1991; 44: 485–495
Duminy PC, Burger P du T . Fetal anbormality associated with the use of captopril during pregnancy. (Letter) S Afr Med J 1981; 60: 805
Mheta N, Modi N . ACE inhibitors in pregnancy (Letter) Lancet 1989; 2: 96
Kreft-Jais C et al. Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22patients given captopril and nine given enalapril Br J Obstet Gynecol 1988; 95: 420–422
Kalter H, Warkany J . Congenital malformations: etiologic factors and their role in prevention N Engl J Med 1983; 308: 491–497
Are ACE inhibitors safe in pregnancy? (editorial) Lancet 1989; 2: 482–483
Shotan A et al. Risks of angiotensin converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms and recommendations for use Am J Med 1994; 96: 451–456
Calhoun DA, Oparil S . High blood pressure in women Int J Fertil 1997; 42: 198–205
Lip GYH et al. Angiotensin converting enzyme inhibitors in early pregnancy Lancet 1997; 350: 1446–1447
Forhead AJ et al. Changes in maternal and fetal renin-angiotensin system in response to angiotensin II type 1 receptor blockade and angiotensin converting enzyme inhibitor in pregnant sheep during late gestation Exp Phys 1997; 82: 761–776
Spence SG et al. Toxicokinetic analysis of losartan during gestation and lactation in the rat Teratology 1996; 53: 245–252
Lambot MA, Vermeylen D, Noel JC . Angiotensin II receptor inhibitors in pregnancy Lancet 2001; 357: 1619–1620
Saji H, Yamanaka M, Hagiwara A, Ijiri R . Losartan and fetal toxic effects (Letter) Lancet 2001; 357: 363
Hinsberger A, Wingen AM, Hoyer PF . (Letter) Lancet 2001; 357: 1620
Chung NA, Lip GH, Beevers M, Beevers DG . Outcomes in women given valsortam early in pregnancy. (Letter) Lancet 2001; 357: 1620
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosenthal, T., Oparil, S. The effect of antihypertensive drugs on the fetus. J Hum Hypertens 16, 293–298 (2002). https://doi.org/10.1038/sj.jhh.1001400
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001400
Keywords
This article is cited by
-
Hypertension in Women: Impact of Contraception, Fertility, and Hormone Treatment
Current Cardiovascular Risk Reports (2022)